OLUMIANT -
ATOPIC DERMATITIS
USA CAMPAIGN
Direct-to-consumer (DTC)
*Under clinical trials, awaiting FDA Final approval
Direct-to-consumer (DTC)
*Under clinical trials, awaiting FDA Final approval
Client:
Eli Lilly US
—
GCD: Josh Eastman
CD: Shawn Taylor / Daug Flynn
ACD/Art: Dan Geva - Ekaterina Goldberg
ACD/Copy: Frank Gillam
Art Director/Graphic Designer: Manuel Benitez
—
Agency:
GREY New York - Toronto
Eli Lilly US
—
GCD: Josh Eastman
CD: Shawn Taylor / Daug Flynn
ACD/Art: Dan Geva - Ekaterina Goldberg
ACD/Copy: Frank Gillam
Art Director/Graphic Designer: Manuel Benitez
—
Agency:
GREY New York - Toronto
Challenge:
Challenging the status quo, we spotlight the hurdles encountered by roughly 16.5 million American adults battling atopic dermatitis (AD), of which 40% contend with moderate to severe symptoms. We aim to elevate awareness and cultivate empathy and support for individuals living with AD.
Issue:
Studies based on patient research reveal a deep recognition that when symptoms of atopic dermatitis appear, a natural response to withdraw from the world arises. The instinct to hide takes root firmly and forces people to seek refuge and hide their true selves.
Solution:
By designing a campaign that illuminates people's daily struggles while treating atopic dermatitis, we aim to vividly illustrate the lengths people go to cope with this condition—highlighting the transformative potential of "Olumiant" to alleviate these challenges associated with AD.
The campaign strategically positions "Olumiant" as a new and effective option for managing atopic dermatitis and relieving the stresses that accompany it.
Using three creative scenarios, we metaphorically represent how AD affects people, causing both a physical and emotional withdrawal from the world. The narrative unfolds to reveal that by using Olumiant, people can emerge from this isolation, experience relief, and live comfortably with better control over their AD symptoms.
"CHANGE YOUR SKIN, NOT YOUR NATURE."
This resonant motto reflects the empowerment of people to manage their AD symptoms while preserving their unique identities and vitality.
Services:
Digital
Social
Retail
Digital
Social
Retail
Photography:
Lightfarm Studios
—
Industry:
Pharmaceuticals, Eli Lilly
Lightfarm Studios
—
Industry:
Pharmaceuticals, Eli Lilly
